Brief: Cormedix Reports Positive Data From Real World Study of Defencath
18/12/2025 13:29
Dec 18 (Reuters) - CorMedix Inc CRMD.O: CORMEDIX THERAPEUTICS ANNOUNCES POSITIVE DATA FROM ONGOING REAL WORLD EVIDENCE STUDY OF DEFENCATH Source text: ID:nGNX7WrJ9l Further company coverage: CRMD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CorMedix
See all newsBrief: Cormedix Announces FDA Acceptance For Priority Review Of Supplemental NDA For Rezzayo
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
CorMedix Inc. reports results for the quarter ended June 30 - Earnings Summary